Ketogenic diet for treatment of infantile spasms

So Hee Eun1, Hoon Chul Kang, Dong Wook Kim

  • 1Department of Pediatrics, Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea.

Brain & Development
|May 16, 2006
PubMed

Insights

The ketogenic diet (KD) effectively treats infantile spasms (IS), with over half of children becoming seizure-free. This revised KD protocol offers a safer, well-tolerated alternative for managing this severe epilepsy condition.

Area of Science:

  • Neurology
  • Pediatric Epilepsy
  • Nutritional Therapy

Background:

  • Infantile spasms (IS) are a severe epilepsy syndrome in infants.
  • Catastrophic IS often presents treatment challenges.
  • Previous ketogenic diet (KD) protocols had limitations.

Purpose of the Study:

  • To evaluate the efficacy, tolerability, and safety of a revised ketogenic diet (KD) protocol for infantile spasms (IS).
  • To assess the impact of KD on seizure frequency, EEG, and neurological development in children with IS.

Main Methods:

  • Retrospective analysis of 43 children with catastrophic IS treated with a revised KD.
  • Data collected from June 1995 to May 2004 across two Korean epilepsy centers.
  • Outcomes included seizure frequency, EEG, adverse events, and neurodevelopmental progress.

Main Results:

  • 53.5% of patients achieved a seizure-free state.
  • 62.8% experienced over a 90% reduction in seizure frequency.
  • Improvements in EEG and neurological development were concordant with seizure control.
  • The revised protocol, featuring a non-fasting start, 8-month trial, 3:1 lipid-to-non-lipid ratio, and liquid formula, enhanced tolerability and safety.
  • Most complications were transient, indicating good overall tolerance.

Conclusions:

  • The revised ketogenic diet is an effective alternative therapy for catastrophic infantile spasms.
  • The modified protocol improves the safety and comfort of KD treatment.
  • Further refinements to the KD protocol may yield additional benefits for IS management.

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...